Most sold healthcare stocks in Q1 2017
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2017, measured as net reductions in reported share positions from Q4 2016 into Q1 2017. Notable reductions at the top of this list include BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), INNOVIVA INC (INVA), AGILENT TECHNOLOGIES INC (A). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | -5,216,595 | $169.99M | 0 | 1 | 4 | 1 | 6 |
| PFE | PFIZER INC | -3,698,914 | -$84.97M | 1 | 5 | 5 | 1 | 15 |
| INVA | INNOVIVA INC | -3,619,277 | $7.42M | 1 | 0 | 2 | 0 | 3 |
| A | AGILENT TECHNOLOGIES INC | -2,970,955 | -$93.00M | 0 | 0 | 2 | 1 | 3 |
| MYGN | MYRIAD GENETICS INC | -2,160,912 | -$31.23M | 0 | 0 | 2 | 0 | 2 |
| COR | CENCORA INC | -1,955,481 | -$92.75M | 0 | 0 | 2 | 2 | 3 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -1,948,467 | -$10.89M | 0 | 0 | 0 | 2 | 0 |
| ELV | ELEVANCE HEALTH INC | -1,602,119 | $20.95M | 0 | 3 | 4 | 0 | 9 |
| BIIB | BIOGEN INC | -1,342,200 | -$396.66M | 1 | 3 | 2 | 1 | 7 |
| THC | TENET HEALTHCARE CORP | -1,325,875 | -$19.68M | 0 | 0 | 0 | 1 | 0 |
| HCA | HCA HEALTHCARE INC | -895,207 | -$8.36M | 1 | 0 | 2 | 0 | 3 |
| PRGO | Perrigo Company PLC | -871,609 | -$148.22M | 1 | 1 | 0 | 3 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -645,200 | -$12.81M | 0 | 0 | 1 | 0 | 1 |
| SNY | SANOFI-ADR | -593,957 | $326.16M | 1 | 0 | 3 | 1 | 6 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -566,628 | -$41.39M | 0 | 0 | 2 | 2 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | -418,215 | $94.00K | 0 | 1 | 1 | 0 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -406,862 | -$45.17M | 1 | 1 | 2 | 1 | 5 |
| ILMN | ILLUMINA INC | -386,193 | -$44.33M | 0 | 0 | 1 | 1 | 2 |
| INCY | INCYTE CORP | -358,504 | -$17.42M | 0 | 0 | 3 | 0 | 3 |
| PINC | PREMIER INC-CLASS A | -355,650 | -$9.11M | 0 | 1 | 1 | 0 | 3 |
| VCEL | VERICEL CORP | -355,300 | -$1.08M | 0 | 0 | 1 | 0 | 1 |
| RMD | RESMED INC | -352,600 | -$21.55M | 0 | 0 | 1 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | -337,233 | $19.54M | 0 | 0 | 2 | 1 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | -321,819 | -$982.00K | 0 | 0 | 0 | 1 | 0 |
| HOLX | HOLOGIC INC | -303,305 | -$5.99M | 0 | 0 | 3 | 0 | 3 |
| AZTA | AZENTA INC | -298,900 | -$2.44M | 0 | 1 | 1 | 0 | 2 |
| RGEN | REPLIGEN CORP | -263,200 | -$5.36M | 0 | 0 | 1 | 0 | 1 |
| AMED | AMEDISYS INC | -237,500 | -$9.91M | 0 | 0 | 1 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | -180,800 | -$8.61M | 0 | 0 | 1 | 0 | 1 |
| HSIC | HENRY SCHEIN INC | -172,096 | -$20.35M | 0 | 0 | 1 | 1 | 2 |
| HSTM | HEALTHSTREAM INC | -168,400 | -$4.22M | 0 | 0 | 0 | 1 | 0 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | -158,018 | -$2.47M | 0 | 0 | 0 | 1 | 0 |
| BIO | BIO-RAD LABORATORIES-A | -153,667 | -$14.97M | 0 | 1 | 1 | 0 | 2 |
| LFCR | LIFECORE BIOMEDICAL INC | -151,438 | -$3.30M | 0 | 0 | 1 | 1 | 1 |
| MOH | MOLINA HEALTHCARE INC | -134,200 | -$15.94M | 0 | 0 | 1 | 0 | 1 |
| INSM | INSMED INC | -120,500 | -$1.59M | 0 | 0 | 0 | 1 | 0 |
| SYK | STRYKER CORP | -120,181 | $76.98M | 1 | 1 | 3 | 0 | 5 |
| ANGO | ANGIODYNAMICS INC | -102,446 | -$1.49M | 0 | 0 | 1 | 0 | 1 |
| ACRS | ACLARIS THERAPEUTICS INC | -86,521 | -$2.11M | 0 | 0 | 1 | 0 | 1 |
| HAE | HAEMONETICS CORP/MASS | -76,600 | -$2.78M | 0 | 0 | 1 | 0 | 1 |
| ARDX | ARDELYX INC | -66,300 | -$941.00K | 0 | 0 | 0 | 1 | 0 |
| CDXS | CODEXIS INC | -64,500 | -$138.00K | 0 | 0 | 1 | 0 | 1 |
| RDNT | RADNET INC | -62,601 | -$683.00K | 0 | 0 | 1 | 0 | 1 |
| ATRC | ATRICURE INC | -57,200 | -$1.12M | 0 | 0 | 0 | 1 | 0 |
| OCUL | OCULAR THERAPEUTIX INC | -56,200 | -$389.00K | 0 | 0 | 1 | 0 | 1 |
| MGNX | MACROGENICS INC | -46,365 | -$1.21M | 1 | 0 | 1 | 1 | 2 |
| OMCL | OMNICELL INC | -44,622 | -$1.39M | 0 | 0 | 1 | 1 | 1 |
| ICUI | ICU MEDICAL INC | -42,851 | -$2.59M | 0 | 0 | 1 | 0 | 1 |
| TBRG | TRUBRIDGE INC | -34,215 | -$807.00K | 0 | 0 | 0 | 1 | 0 |
| PMD | PSYCHEMEDICS CORP | -32,590 | -$2.97M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q1 2017
What are the most sold Healthcare stocks in Q1 2017?
The most sold healthcare stocks in Q1 2017 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2017?
Among filers in this sector, net reductions were largest in companies such as BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), INNOVIVA INC (INVA), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.